Leslie S Wilson

Summary

Affiliation: University of California
Country: USA

Publications

  1. doi request reprint Fee comparisons of treatments for nonmelanoma skin cancer in a private practice academic setting
    Leslie S Wilson
    University of California at San Francisco, San Francisco, California 94013, USA
    Dermatol Surg 38:570-84. 2012
  2. doi request reprint The effect of prophylaxis on pediatric HIV costs
    Leslie S Wilson
    Department of Clinical Pharmacy, University of California, San Francisco, USA
    AIDS Care 24:108-18. 2012
  3. ncbi request reprint Cumulative cost pattern comparison of prostate cancer treatments
    Leslie S Wilson
    Department of Medicine, University of California, San Francisco, California 94143, USA
    Cancer 109:518-27. 2007
  4. ncbi request reprint Cost-effectiveness of implementation methods for ELISA serology testing of Trypanosoma cruzi in California blood banks
    Leslie S Wilson
    University of California, San Francisco, California 94010 0613, USA
    Am J Trop Med Hyg 79:53-68. 2008
  5. doi request reprint Pediatric HIV costs across three treatment eras from 1986 to 2007
    Leslie S Wilson
    Department of Medicine, University of California San Francisco, 3333 California St, Suite 420, Box 0613, San Francisco, CA 94143, USA
    Pediatrics 126:e541-9. 2010
  6. pmc The economic burden of home care for children with HIV and other chronic illnesses
    Leslie S Wilson
    University of California, San Francisco, 3333 California, Box 0613, Suite 420M, San Francisco, CA 94143, USA
    Am J Public Health 95:1445-52. 2005
  7. ncbi request reprint Comparison of selection strategies for genetic testing of patients with hereditary nonpolyposis colorectal carcinoma: effectiveness and cost-effectiveness
    Carolina M Reyes
    Department of Clinical Pharmacy, University of California, San Francisco 94143, USA
    Cancer 95:1848-56. 2002
  8. ncbi request reprint The direct cost and incidence of systemic fungal infections
    Leslie S Wilson
    Department of Clinical Pharmacy, University of California San Francisco, 3333 California Street, Suite 420M, San Francisco, CA 94118, USA
    Value Health 5:26-34. 2002
  9. ncbi request reprint Cost-effectiveness of Chagas disease interventions in latin america and the Caribbean: Markov models
    Leslie S Wilson
    Departments of Medicine and Pharmacy, University of California, San Francisco, California 94143, USA
    Am J Trop Med Hyg 73:901-10. 2005

Detail Information

Publications9

  1. doi request reprint Fee comparisons of treatments for nonmelanoma skin cancer in a private practice academic setting
    Leslie S Wilson
    University of California at San Francisco, San Francisco, California 94013, USA
    Dermatol Surg 38:570-84. 2012
    ..To compare fees for biopsy, treatment procedure, repair, and 2-month follow-up for nonmelanoma skin cancer (NMSC) treatments: electrodesiccation and curettage (ED&C), excision, and Mohs micrographic surgery (MMS)...
  2. doi request reprint The effect of prophylaxis on pediatric HIV costs
    Leslie S Wilson
    Department of Clinical Pharmacy, University of California, San Francisco, USA
    AIDS Care 24:108-18. 2012
    ....
  3. ncbi request reprint Cumulative cost pattern comparison of prostate cancer treatments
    Leslie S Wilson
    Department of Medicine, University of California, San Francisco, California 94143, USA
    Cancer 109:518-27. 2007
    ..The authors compared healthcare utilization and cost patterns of prostate cancer treatments over a span of 5.5 years in 4553 newly diagnosed patients stratified by age and risk group...
  4. ncbi request reprint Cost-effectiveness of implementation methods for ELISA serology testing of Trypanosoma cruzi in California blood banks
    Leslie S Wilson
    University of California, San Francisco, California 94010 0613, USA
    Am J Trop Med Hyg 79:53-68. 2008
    ..The best strategy depends on site-specific risk. Census estimates of Hispanics do not predict donor risk well. We suggest using our screening questions to determine risk level and most cost-effective testing strategy...
  5. doi request reprint Pediatric HIV costs across three treatment eras from 1986 to 2007
    Leslie S Wilson
    Department of Medicine, University of California San Francisco, 3333 California St, Suite 420, Box 0613, San Francisco, CA 94143, USA
    Pediatrics 126:e541-9. 2010
    ..We also estimated cumulative health care costs among pediatric HIV/AIDS patients born in each era...
  6. pmc The economic burden of home care for children with HIV and other chronic illnesses
    Leslie S Wilson
    University of California, San Francisco, 3333 California, Box 0613, Suite 420M, San Francisco, CA 94143, USA
    Am J Public Health 95:1445-52. 2005
    ....
  7. ncbi request reprint Comparison of selection strategies for genetic testing of patients with hereditary nonpolyposis colorectal carcinoma: effectiveness and cost-effectiveness
    Carolina M Reyes
    Department of Clinical Pharmacy, University of California, San Francisco 94143, USA
    Cancer 95:1848-56. 2002
    ..Molecular testing for hereditary nonpolyposis colorectal carcinoma (HNPCC) is becoming standard care and it is cost-effective compared with no genetic testing. However, the best strategy for detection of HNPCC gene carriers is unknown...
  8. ncbi request reprint The direct cost and incidence of systemic fungal infections
    Leslie S Wilson
    Department of Clinical Pharmacy, University of California San Francisco, 3333 California Street, Suite 420M, San Francisco, CA 94118, USA
    Value Health 5:26-34. 2002
    ..In this study we determined the incidence and direct inpatient and outpatient costs of systemic fungal infections (candidiasis, aspergillosis, cryptococcosis, histoplasmosis) in 1998...
  9. ncbi request reprint Cost-effectiveness of Chagas disease interventions in latin america and the Caribbean: Markov models
    Leslie S Wilson
    Departments of Medicine and Pharmacy, University of California, San Francisco, California 94143, USA
    Am J Trop Med Hyg 73:901-10. 2005
    ..The best strategy to combat Chagas disease is combinations of vector control and a potential new drug...